ANIDULAFUNGIN Labatec subst sèche 100 mg flac
7680677560019
CH-67756
J02AX06
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Anidulafungin Labatec 100 mg, Poudre pour solution à diluer pour perfusion
Puder
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
anidulafunginum
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
fructosum
|
100.0 MG | Substance | HBESI |
|
mannitolum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
acidum tartaricum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
natrium
|
- | Substance | HBESI |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 67756
- Drug name
- Anidulafungin Labatec 100 mg, Poudre pour solution à diluer pour perfusion
- Galenic form
- PULPI
- ATC Code
- J02AX06
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 21/12/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 08.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ANIDULAFUNGIN Labatec subst sèche 100 mg flac
- Description (DE)
- ANIDULAFUNGIN Labatec Trockensub 100 mg Durchstf
- Market launch
- 21/12/2020
- Narcotic (BTM)
- No
Available generics
Anidulafungin Accord, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680683570019
CHF 381.95
Anidulafungin Pfizer 100 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
GTIN:
7680675730018
CHF 381.95